Can a new care plan tame dangerous potassium in kidney patients?

NCT ID NCT06884267

Recruiting now Disease control Sponsor: AstraZeneca Source: ClinicalTrials.gov ↗

Summary

This study aims to see if a standardized care program can help doctors better manage high potassium levels in patients with chronic kidney disease. About 1,000 adult patients in China will follow a specific management plan, including education, regular blood tests, and medication adjustments. The goal is to keep potassium levels in a safe range while allowing patients to take important heart and kidney medications.

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Show contact details

Study contacts

Contact

Phone: •••-•••-•••• Email: •••••@•••••

Locations

Research Site
NOT_YET_RECRUITING

Beijing, 100029, China
Research Site
NOT_YET_RECRUITING

Benxi, 117000, China
Research Site
NOT_YET_RECRUITING

Changchun, 130041, China
Research Site
RECRUITING

Changsha, 410008, China
Research Site
NOT_YET_RECRUITING

Changsha, 410013, China
Research Site
NOT_YET_RECRUITING

Changsha, 410300, China
Research Site
NOT_YET_RECRUITING

Chengdu, 610031, China
Research Site
NOT_YET_RECRUITING

Chengdu, 610041, China
Research Site
NOT_YET_RECRUITING

Chengdu, 610078, China
Research Site
NOT_YET_RECRUITING

Chongqing, 400042, China
Research Site
NOT_YET_RECRUITING

Dalian, 116023, China
Research Site
NOT_YET_RECRUITING

Fuyang, 236600, China
Research Site
NOT_YET_RECRUITING

Fuzhou, 350005, China
Research Site
NOT_YET_RECRUITING

Fuzhou, 350031, China
Research Site
NOT_YET_RECRUITING

Gejiu, 661099, China
Research Site
NOT_YET_RECRUITING

Guangzhou, 510280, China
Research Site
NOT_YET_RECRUITING

Guangzhou, 510530, China
Research Site
NOT_YET_RECRUITING

Guiyang, 510630, China
Research Site
NOT_YET_RECRUITING

Haikou, 570311, China
Research Site
NOT_YET_RECRUITING

Hangzhou, 310006, China
Research Site
NOT_YET_RECRUITING

Hefei, 230001, China
Research Site
NOT_YET_RECRUITING

Hohhot, 10050, China
Research Site
NOT_YET_RECRUITING

Jinan, 250012, China
Research Site
NOT_YET_RECRUITING

Jinan, 250021, China
Research Site
NOT_YET_RECRUITING

Kunming, 650021, China
Research Site
NOT_YET_RECRUITING

Kunming, 650101, China
Research Site
NOT_YET_RECRUITING

Lanzhou, 730030, China
Research Site
NOT_YET_RECRUITING

Nanchang, 330006, China
Research Site
NOT_YET_RECRUITING

Nanning, 530021, China
Research Site
NOT_YET_RECRUITING

Nantong, 226001, China
Research Site
NOT_YET_RECRUITING

Ningbo, 315010, China
Research Site
NOT_YET_RECRUITING

Pingdingshan, 467000, China
Research Site
NOT_YET_RECRUITING

Qiqihar, 161000, China
Research Site
RECRUITING

Shanghai, 200025, China
Research Site
RECRUITING

Shanghai, 200032, China
Research Site
RECRUITING

Shanghai, 200233, China
Research Site
NOT_YET_RECRUITING

Shenyang, 110001, China
Research Site
NOT_YET_RECRUITING

Shijiazhuang, 50051, China
Research Site
NOT_YET_RECRUITING

Taiyuan, 030001, China
Research Site
NOT_YET_RECRUITING

Tianjin, 300192, China
Research Site
NOT_YET_RECRUITING

Ürümqi, 830054, China
Research Site
NOT_YET_RECRUITING

Wuhan, 430022, China
Research Site
NOT_YET_RECRUITING

Wuhu, 241000, China
Research Site
RECRUITING

Wuxi, 214062, China
Research Site
NOT_YET_RECRUITING

Xi'an, 710061, China
Research Site
NOT_YET_RECRUITING

Xining, 810001, China
Research Site
NOT_YET_RECRUITING

Xinxiang, 453100, China
Research Site
NOT_YET_RECRUITING

Yinchuan, 750004, China
Research Site
NOT_YET_RECRUITING

Zhengzhou, 450003, China

Conditions

Explore the condition pages connected to this study.

HYPERKALEMIA